The most common side effects are GI-related
Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study
13 C NMR (100 MHz, DMSO-d 6 ) = 110.6, 102.5, 88.3, 86.5, 31.8, 22.5, 20.5, 20.4
Glucose-6-Phosphate Dehydrogenase Deficiency - ClinicalKey
High expression of Autophagy Related Proteins Negatively Impacts Clinical Outcomes in Acute Myelogenous Leukema- Time to Target Autophagy to Improve Therapy Outcomes
Therapeutic effect Contrasted with the whole effective percentage of remedy of patients in the control group, which was 82.22% (37/45), the whole effective percentage of remedy of patients in the observation group was 95.56% (43/45), which was significantly increased ( P 0.05)